The article discusses the move to rename low-grade cancers to avoid scaring patients, but the article also raises concerns about active surveillance and the lack of cell biological activity measurement.
The debate over renaming low-risk cancers chippewa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chippewa.com Daily Mail and Mail on Sunday newspapers.
The article discusses the move to rename low-grade cancers to avoid scaring patients, but the article also raises concerns about active surveillance and the lack of cell biological activity measurement.
The Messenger - The News in Brief messenger.com.ge - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from messenger.com.ge Daily Mail and Mail on Sunday newspapers.
Insights on real-world ponatinib treatment strategies and safety in Philadelphia-positive acute lymphoblastic leukemia are provided by Hagop Kantarjian, MD, and Bijal D. Shah, MD, MS.